Protein-energy wasting modifies the association of ghrelin with inflammation, leptin, and mortality in hemodialysis patients

Kidney International

Volumn 79, Issue 7, 2011, Pages 749-756

  Carrero, Juan J ^a   Nakashima, Ayumu ^a   Qureshi, Abdul R ^a   Lindholm, Bengt ^a   Heimbürger, Olof ^a   Bárány, Peter ^a   Stenvinkel, Peter ^a,b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

anorexia; appetite; leptin; malnutrition; outcome

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; GHRELIN; LEPTIN;

ADULT; AGED; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; COMORBIDITY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; ENERGY EXPENDITURE; FEMALE; HEMODIALYSIS; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; MORTALITY; MUSCLE ATROPHY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN ENERGY WASTING;

EID: 79952689406     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2010.487     Document Type: Article

References (48)

1. Fouque D, Kalantar-Zadeh K, Kopple J et al. A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease. Kidney Int 2008; 73: 391-398. (Pubitemid 351186278)
2. Carrero JJ. Identification of patients with eating disorders: clinical and biochemical signs of appetite loss in dialysis patients. J Ren Nutr 2009; 19: 10-15.
3. Avesani CM, Carrero JJ, Axelsson J et al. Inflammation and wasting in chronic kidney disease: partners in crime. Kidney Int Suppl 2006; 70: S8-S13. (Pubitemid 44764120)
4. Carrero JJ, Qureshi AR, Axelsson J et al. Comparison of nutritional and inflammatory markers in dialysis patients with reduced appetite. Am J Clin Nutr 2007; 85: 695-701. (Pubitemid 46393499)
5. Kalantar-Zadeh K, Block G, McAllister CJ et al. Appetite and inflammation, nutrition, anemia, and clinical outcome in hemodialysis patients. Am J Clin Nutr 2004; 80: 299-307. (Pubitemid 41080002)
6. Carrero JJ, Aguilera A, Stenvinkel P et al. Appetite disorders in uremia. J Ren Nutr 2008; 18: 107-113. (Pubitemid 350251837)
7. Bossola M, Tazza L, Giungi S et al. Anorexia in hemodialysis patients: an update. Kidney Int 2006; 70: 417-422. (Pubitemid 44141567)
8. Aguilera A, Codoceo R, Bajo MA et al. Eating behavior disorders in uremia: a question of balance in appetite regulation. Semin Dial 2004; 17: 44-52. (Pubitemid 38376691)
9. Nagaya N, Kojima M, Uematsu M et al. Hemodynamic and hormonal effects of human ghrelin in healthy volunteers. Am J Physiol Regul Integr Comp Physiol 2001; 280: R1483-R1487.
10. Nakazato M, Murakami N, Date Y et al. A role for ghrelin in the central regulation of feeding. Nature 2001; 409: 194-198. (Pubitemid 32144284)
11. Rodriguez Ayala E, Pecoits-Filho R, Heimburger O et al. Associations between plasma ghrelin levels and body composition in end-stage renal disease: a longitudinal study. Nephrol Dial Transplant 2004; 19: 421-426. (Pubitemid 38195993)
12. Yoshimoto A, Mori K, Sugawara A et al. Plasma ghrelin and desacyl ghrelin concentrations in renal failure. J Am Soc Nephrol 2002; 13: 2748-2752. (Pubitemid 35216044)
13. Wynne K, Giannitsopoulou K, Small CJ et al. Subcutaneous ghrelin enhances acute food intake in malnourished patients who receive maintenance peritoneal dialysis: a randomized, placebo-controlled trial. J Am Soc Nephrol 2005; 16: 2111-2118. (Pubitemid 41716442)
14. Ashby DR, Ford HE, Wynne KJ et al. Sustained appetite improvement in malnourished dialysis patients by daily ghrelin treatment. Kidney Int 2009; 76: 199-206.
15. Niemczyk S, Sikorska H, Wiecek A et al. A super-agonist of growth hormone-releasing hormone causes rapid improvement of nutritional status in patients with chronic kidney disease. Kidney Int 2010; 77: 450-458.
16. Nagaya N, Moriya J, Yasumura Y et al. Effects of ghrelin administration on left ventricular function, exercise capacity, and muscle wasting in patients with chronic heart failure. Circulation 2004; 110: 3674-3679. (Pubitemid 39665256)
17. Nagaya N, Uematsu M, Kojima M et al. Chronic administration of ghrelin improves left ventricular dysfunction and attenuates development of cardiac cachexia in rats with heart failure. Circulation 2001; 104: 1430-1435. (Pubitemid 32880158)
18. Ashitani J, Matsumoto N, Nakazato M. Ghrelin and its therapeutic potential for cachectic patients. Peptides 2009; 30: 1951-1956.
19. Li WG, Gavrila D, Liu X et al. Ghrelin inhibits proinflammatory responses and nuclear factor-kappaB activation in human endothelial cells. Circulation 2004; 109: 2221-2226. (Pubitemid 38625400)
20. Dixit VD, Schaffer EM, Pyle RS et al. Ghrelin inhibits leptin- and activation-induced proinflammatory cytokine expression by human monocytes and T cells. J Clin Invest 2004; 114: 57-66. (Pubitemid 39071644)
21. Deboer MD, Zhu X, Levasseur PR et al. Ghrelin treatment of chronic kidney disease: improvements in lean body mass and cytokine profile. Endocrinology 2008; 149: 827-835. (Pubitemid 351159354)
22. DeBoer MD, Zhu XX, Levasseur P et al. Ghrelin treatment causes increased food intake and retention of lean body mass in a rat model of cancer cachexia. Endocrinology 2007; 148: 3004-3012. (Pubitemid 46984811)
23. Lee CC, Lee RP, Subeq YM et al. Fasting serum total ghrelin level inversely correlates with metabolic syndrome in hemodialysis patients. Arch Med Res 2008; 39: 785-790.
24. Poykko SM, Kellokoski E, Horkko S et al. Low plasma ghrelin is associated with insulin resistance, hypertension, and the prevalence of type 2 diabetes. Diabetes 2003; 52: 2546-2553. (Pubitemid 37210544)
25. Poykko SM, Kellokoski E, Ukkola O et al. Plasma ghrelin concentrations are positively associated with carotid artery atherosclerosis in males. J Intern Med 2006; 260: 43-52. (Pubitemid 43894069)
26. Tschop M, Weyer C, Tataranni PA et al. Circulating ghrelin levels are decreased in human obesity. Diabetes 2001; 50: 707-709. (Pubitemid 32242624)
27. Gilg S, Lutz TA. The orexigenic effect of peripheral ghrelin differs between rats of different age and with different baseline food intake, and it may in part be mediated by the area postrema. Physiol Behav 2006; 87: 353-359. (Pubitemid 43188831)
28. Tolle V, Kadem M, Bluet-Pajot MT et al. Balance in ghrelin and leptin plasma levels in anorexia nervosa patients and constitutionally thin women. J Clin Endocrinol Metab 2003; 88: 109-116. (Pubitemid 36115151)
29. Germain N, Galusca B, Le Roux CW et al. Constitutional thinness and lean anorexia nervosa display opposite concentrations of peptide YY, glucagon-like peptide 1, ghrelin, and leptin. Am J Clin Nutr 2007; 85: 967-971. (Pubitemid 46557910)
30. Barazzoni R, Zhu X, Deboer M et al. Combined effects of ghrelin and higher food intake enhance skeletal muscle mitochondrial oxidative capacity and AKT phosphorylation in rats with chronic kidney disease. Kidney Int 2010; 77: 23-28.
31. Schwenke DO, Tokudome T, Kishimoto I et al. Early ghrelin treatment after myocardial infarction prevents an increase in cardiac sympathetic tone and reduces mortality. Endocrinology 2008; 149: 5172-5176.
32. Baldanzi G, Filigheddu N, Cutrupi S et al. Ghrelin and des-acyl ghrelin inhibit cell death in cardiomyocytes and endothelial cells through ERK1/2 and PI 3-kinase/AKT. J Cell Biol 2002; 159: 1029-1037. (Pubitemid 36055757)
33. Soeki T, Kishimoto I, Schwenke DO et al. Ghrelin suppresses cardiac sympathetic activity and prevents early left ventricular remodeling in rats with myocardial infarction. Am J Physiol Heart Circ Physiol 2008; 294: H426-H432.
34. Lasseter KC, Shaughnessy L, Cummings D et al. Ghrelin agonist (TZP-101): safety, pharmacokinetics and pharmacodynamic evaluation in healthy volunteers: a phase I, first-in-human study. J Clin Pharmacol 2008; 48: 193-202.
35. Caliskan Y, Gorgulu N, Yelken B et al. Plasma ghrelin levels are associated with coronary microvascular and endothelial dysfunction in peritoneal dialysis patients. Ren Fail 2009; 31: 807-813.
36. Chang CC, Hung CH, Yen CS et al. The relationship of plasma ghrelin level to energy regulation, feeding and left ventricular function in non-diabetic haemodialysis patients. Nephrol Dial Transplant 2005; 20: 2172-2177.
37. Kohno D, Nakata M, Maekawa F et al. Leptin suppresses ghrelin-induced activation of neuropeptide Y neurons in the arcuate nucleus via phosphatidylinositol 3-kinase- and phosphodiesterase 3-mediated pathway. Endocrinology 2007; 148: 2251-2263. (Pubitemid 46997030)
38. Carrero JJ, Cordeiro AC, Lindholm B et al. The emerging pleiotrophic role of adipokines in the uremic phenotype. Curr Opin Nephrol Hypertens 2010; 19: 37-42.
39. Chen K, Li F, Li J et al. Induction of leptin resistance through direct interaction of C-reactive protein with leptin. Nat Med 2006; 12: 425-432.
40. Carrero JJ, Stenvinkel P. Persistent inflammation as a catalyst for other risk factors in chronic kidney disease: a hypothesis proposal. Clin J Am Soc Nephrol 2009; 4(Suppl 1): S49-S55.
41. Carrero JJ, Stenvinkel P. Nutrition: can ghrelin improve appetite in uremic wasting? Nat Rev Nephrol 2009; 5: 672-673.
42. Perez-Fontan M, Cordido F, Rodriguez-Carmona A et al. Acute plasma ghrelin and leptin responses to oral feeding or intraperitoneal hypertonic glucose-based dialysate in patients with chronic renal failure. Kidney Int 2005; 68: 2877-2885. (Pubitemid 43251035)
43. Votruba SB, Kirchner H, Tschop M et al. Morning ghrelin concentrations are not affected by short-term overfeeding and do not predict ad libitum food intake in humans. Am J Clin Nutr 2009; 89: 801-806.
44. Weigle DS, Breen PA, Matthys CC et al. A high-protein diet induces sustained reductions in appetite, ad libitum caloric intake, and body weight despite compensatory changes in diurnal plasma leptin and ghrelin concentrations. Am J Clin Nutr 2005; 82: 41-48. (Pubitemid 41716375)
45. Ulander K, Grahn G, Jeppsson B. Subjective assessment of nutritional status-validity and reliability of a modified Detsky index in a Swedish setting. Clin Nutr (Edinburgh, Scotland) 1993; 12: 15-19. (Pubitemid 23092556)
46. Qureshi AR, Alvestrand A, Danielsson A et al. Factors predicting malnutrition in hemodialysis patients: a cross-sectional study. Kidney Int 1998; 53: 773-782. (Pubitemid 28124295)
47. Detsky AS, McLaughlin JR, Baker JP et al. What is subjective global assessment of nutritional status? J Parenter Enteral Nutr 1987; 11: 8-13. (Pubitemid 17009508)
48. Cooper BA, Bartlett LH, Aslani A et al. Validity of subjective global assessment as a nutritional marker in end-stage renal disease. Am J Kidney Dis 2002; 40: 126-132. (Pubitemid 34701220)